Incidence of chemotherapy-induced peripheral neuropathy within 12 weeks of starting neurotoxic chemotherapy for multiple myeloma or lymphoma: a prospective, single-center, observational study.

Veronica B AjewoleJames E CoxJoshua T SwanSoumya G ChikermaneBeverly LamothTomona IsoLaura O OkoloChristen L FordAmy M SchneiderEleanor C HobaughKelty R Baker

Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2019)

Sixty-seven percent of patients experienced clinically significant CIPN within 12 weeks of starting chemotherapy. Feasibility metrics for enrollment, consent, CIPN assessment, and follow-up were met.

Keyphrases

chemotherapy induced
end stage renal disease
multiple myeloma
chronic kidney disease
newly diagnosed
ejection fraction
peritoneal dialysis
risk factors
health insurance
radiation therapy
preterm birth